{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T21:37:48Z","timestamp":1772660268636,"version":"3.50.1"},"reference-count":46,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["\u201cPTDC\/EBB-BIO\/119356\/2010, PTDC\/BBB-BIO\/4004\/2014, UID\/BIO\/04565\/2013, SFRH\/BPD\/100863\/2014\u201d"],"award-info":[{"award-number":["\u201cPTDC\/EBB-BIO\/119356\/2010, PTDC\/BBB-BIO\/4004\/2014, UID\/BIO\/04565\/2013, SFRH\/BPD\/100863\/2014\u201d"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2016.00526","type":"journal-article","created":{"date-parts":[[2016,4,19]],"date-time":"2016-04-19T03:26:12Z","timestamp":1461036372000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":31,"title":["Clotrimazole Drug Resistance in Candida glabrata Clinical Isolates Correlates with Increased Expression of the Drug:H+ Antiporters CgAqr1, CgTpo1_1, CgTpo3, and CgQdr2"],"prefix":"10.3389","volume":"7","author":[{"given":"Catarina","family":"Costa","sequence":"first","affiliation":[]},{"given":"Jonathan","family":"Ribeiro","sequence":"additional","affiliation":[]},{"given":"Isabel M.","family":"Miranda","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Silva-Dias","sequence":"additional","affiliation":[]},{"given":"Mafalda","family":"Cavalheiro","sequence":"additional","affiliation":[]},{"given":"Sofia","family":"Costa-de-Oliveira","sequence":"additional","affiliation":[]},{"given":"Ac\u00e1cio G.","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"Miguel C.","family":"Teixeira","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2016,4,19]]},"reference":[{"issue":"74","key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2013.00074","article-title":"Interactions between copy number and expression level of genes involved in fluconazole resistance in Candida glabrata.","volume":"3","author":"Abbes","year":"2013","journal-title":"Front. Cell Infect Microbiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1128\/AAC.48.5.1773-1777.2004","article-title":"Mechanism of increased fluconazole resistance in Candida glabrata during prophylaxis.","volume":"48","author":"Bennett","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"B3","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1128\/CMR.00051-08","article-title":"E\ufb04ux-mediated antifungal drug resistance.","volume":"22","author":"Cannon","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1128\/EC.00073-10","article-title":"Genome-wide expression profile analysis of the Candida glabrata Pdr1 regulon.","volume":"10","author":"Caudle","year":"2011","journal-title":"Eukaryot. Cell"},{"key":"B5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.gene.2006.08.010","article-title":"The bZip transcription factor Cgap1p is involved in multidrug resistance and required for activation of multidrug transporter gene CgFLR1 in Candida glabrata.","volume":"386","author":"Chen","year":"2007","journal-title":"Gene"},{"key":"B6","author":"CLSI","year":"2008","journal-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts, CLSI M27-A3,"},{"key":"B7","author":"CLSI","year":"2012","journal-title":"M27-S4 Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Fourth Informational Supplement."},{"issue":"197","key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2014.00197","article-title":"MFS multidrug transporters in pathogenic fungi: do they have real clinical impact?","volume":"5","author":"Costa","year":"2014a","journal-title":"Front. Physiol."},{"issue":"170","key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2013.00170","article-title":"The dual role of Candida glabrata drug:H+ antiporter CgAqr1 (ORF CAGL0J09944g) in antifungal drug and acetic acid resistance.","volume":"4","author":"Costa","year":"2013a","journal-title":"Front. Microbiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1093\/jac\/dku044","article-title":"Candida glabrata drug:H+ antiporter CgTpo3 (ORF CAGL0I10384g): role in azole drug resistance and polyamine homeostasis.","volume":"69","author":"Costa","year":"2014b","journal-title":"J. Antimicrob. Chemother."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1128\/AAC.00811-12","article-title":"Candida glabrata drug:H+ antiporter CgQdr2 confers imidazole drug resistance, being activated by transcription factor CgPdr1.","volume":"57","author":"Costa","year":"2013b","journal-title":"Antimicrob. Agents Chemother."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1128\/AAC.00589-10","article-title":"FKS2 mutations associated with decreased echinocandin susceptibility of Candida glabrata following anidulafungin therapy.","volume":"55","author":"Costa-de-Oliveira","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B13","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s10096-007-0448-4","article-title":"A first Portuguese epidemiological survey of fungaemia in a university hospital.","volume":"27","author":"Costa-de-Oliveira","year":"2008","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1089\/107662900419474","article-title":"Cross-resistance of clinical isolates of Candida albicans and Candida glabrata to over-the-counter azoles used in the treatment of vaginitis.","volume":"6","author":"Cross","year":"2000","journal-title":"Microb. Drug Resist."},{"key":"B15","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/jam.12554","article-title":"Clotrimazole as a pharmaceutical: past, present and future.","volume":"117","author":"Crowley","year":"2014","journal-title":"J. Appl. Microbiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3644","DOI":"10.1128\/AAC.46.11.3644-3647.2002","article-title":"Comparative evaluation of NCCLS M27-A and EUCAST broth microdilution procedures for antifungal susceptibility testing of Candida species.","volume":"46","author":"Cuenca-Estrella","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1007\/s10096-014-2194-8","article-title":"Species distribution and in vitro antifungal susceptibility profiles of yeast isolates from invasive infections during a Portuguese multicenter survey.","volume":"33","author":"Faria-Ramos","year":"2014","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1128\/AAC.44.10.2693-2700.2000","article-title":"Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors.","volume":"44","author":"Henry","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"B19","doi-asserted-by":"publisher","first-page":"4527","DOI":"10.1128\/AAC.00348-10","article-title":"Identification and characterization of four azole-resistant erg3 mutants of Candida albicans.","volume":"54","author":"Martel","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B20","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1128\/AAC.42.7.1695","article-title":"Fluconazole resistance associated with drug e\ufb04ux and increased transcription of a drug transporter gene, PDH1, in Candida glabrata.","volume":"42","author":"Miyazaki","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"B21","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.fgb.2009.08.002","article-title":"Regulation of multidrug resistance in pathogenic fungi.","volume":"47","author":"Morschhauser","year":"2010","journal-title":"Fungal Genet. Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1074\/mcp.M114.045344","article-title":"Membrane proteome-wide response to the antifungal drug clotrimazole in Candida glabrata: role of the transcription factor CgPdr1 and the Drug:H+ Antiporters CgTpo1_1 and CgTpo1_2.","volume":"15","author":"Pais","year":"2016","journal-title":"Mol. Cell. Proteomics"},{"issue":"e1003550","key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003550","article-title":"Emerging and emerged pathogenic Candida species: beyond the Candida albicans paradigm.","volume":"9","author":"Papon","year":"2013","journal-title":"PLoS Pathog."},{"key":"B24","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1128\/JCM.38.4.1563-1568.2000","article-title":"Emergence of resistance of Candida albicans to clotrimazole in human immunodeficiency virus-infected children: in vitro and clinical correlations.","volume":"38","author":"Pelletier","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1128\/JCM.02441-10","article-title":"Comparison of the broth microdilution (BMD) method of the european committee on antimicrobial susceptibility testing with the 24-hour CLSI BMD method for testing susceptibility of Candida species to fluconazole, posaconazole, and voriconazole by use of epidemiological cutoff values.","volume":"49","author":"Pfaller","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1128\/JCM.42.7.3137-3141.2004","article-title":"Cross-resistance between fluconazole and ravuconazole and the use of fluconazole as a surrogate marker to predict susceptibility and resistance to ravuconazole among 12,796 clinical isolates of Candida spp.","volume":"42","author":"Pfaller","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"B27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1128\/JCM.01551-06","article-title":"Use of fluconazole as a surrogate marker to predict susceptibility and resistance to voriconazole among 13,338 clinical isolates of Candida spp. Tested by clinical and laboratory standards institute-recommended broth microdilution methods.","volume":"45","author":"Pfaller","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1128\/JCM.01952-07","article-title":"Selection of a surrogate agent (fluconazole or voriconazole) for initial susceptibility testing of posaconazole against Candida spp.: results from a global antifungal surveillance program.","volume":"46","author":"Pfaller","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1099\/0022-1317-50-4-375","article-title":"Susceptibility to fluconazole of Candida clinical isolates determined by FUN-1 staining with flow cytometry and epifluorescence microscopy.","volume":"50","author":"Pina-Vaz","year":"2001","journal-title":"J. Med. Microbiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.gene.2004.06.021","article-title":"The SAT1 flipper, an optimized tool for gene disruption in Candida albicans.","volume":"341","author":"Reuss","year":"2004","journal-title":"Gene"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1016\/j.ejmech.2008.07.012","article-title":"Design, synthesis, and antifungal activity of triazole and benzotriazole derivatives.","volume":"44","author":"Rezaei","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s10096-013-2009-3","article-title":"Candida glabrata: a review of its features and resistance.","volume":"33","author":"Rodrigues","year":"2014","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1469-0691.2003.00789.x","article-title":"Method for the determination of minimum inhibitory concentration (MIC) by broth dilution of fermentative yeasts.","volume":"9","author":"Rodr\u00edguez-Tudela","year":"2003","journal-title":"Clin. Microbiol. Infect"},{"key":"B34","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1128\/JCM.01969-06","article-title":"Statistical analyses of correlation between fluconazole MICs for Candida spp. assessed by standard methods set forth by the european committee on antimicrobial susceptibility testing (E.Dis. 7.1) and CLSI (M27-A2).","volume":"45","author":"Rodriguez-Tudela","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1574-6968.2010.02102.x","article-title":"From Saccharomyces cerevisiae to Candida glabratain a few easy steps: important adaptations for an opportunistic pathogen.","volume":"314","author":"Roetzer","year":"2011","journal-title":"FEMS Microbiol. Lett."},{"key":"B36","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1574-6968.1996.tb08000.x","article-title":"Intracellular acidification does not account for inhibition of Saccharomyces cerevisiae growth in the presence of ethanol.","volume":"135","author":"Rosa","year":"1996","journal-title":"FEMS Microbiol. Lett."},{"key":"B37","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1128\/AAC.43.11.2753","article-title":"The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents.","volume":"43","author":"Sanglard","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1128\/AAC.39.11.2378","article-title":"Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.","volume":"39","author":"Sanglard","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"B39","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1128\/AAC.49.2.668-679.2005","article-title":"Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.","volume":"49","author":"Sanguinetti","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"B40","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.1128\/AAC.01127-10","article-title":"Transcriptional profiling of azole-resistant Candida parapsilosis strains.","volume":"55","author":"Silva","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B41","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1099\/jmm.0.000062","article-title":"Mechanisms of azole resistance among clinical isolates of Candida glabrata in Poland.","volume":"64","author":"Szweda","year":"2015","journal-title":"J. Med. Microbiol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1128\/AAC.48.10.3773-3781.2004","article-title":"Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor.","volume":"48","author":"Vermitsky","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"B43","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1128\/AAC.41.7.1482","article-title":"Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus.","volume":"41","author":"White","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"B44","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1128\/JB.182.2.400-404.2000","article-title":"Activation of the multiple drug resistance gene MDR1 in fluconazole-resistant, clinical Candida albicans strains is caused by mutations in a trans-regulatory factor.","volume":"182","author":"Wirsching","year":"2000a","journal-title":"J. Bacteriol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1046\/j.1365-2958.2000.01899.x","article-title":"Targeted gene disruption in Candida albicans wild-type strains: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates.","volume":"36","author":"Wirsching","year":"2000b","journal-title":"Mol. Microbiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2147\/TCRM.S40160","article-title":"Epidemiology and risk factors for invasive candidiasis.","volume":"10","author":"Yapar","year":"2014","journal-title":"Ther. Clin. Risk Manag."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"deposited":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T20:59:22Z","timestamp":1600462762000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fmicb.2016.00526\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,19]]},"references-count":46,"URL":"https:\/\/doi.org\/10.3389\/fmicb.2016.00526","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,19]]}}}